These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12095096)

  • 1. Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.
    Jackson WB; Low DE; Dattani D; Whitsitt PF; Leeder RG; MacDougall R
    Can J Ophthalmol; 2002 Jun; 37(4):228-37; discussion 237. PubMed ID: 12095096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy assessment of azithromycin 1.5% eye drops versus tobramycin 0.3% on clinical signs of purulent bacterial conjunctivitis].
    Robert PY; Bourcier T; Meddeb-Ouertani A; Khairallah M; Zaghloul K; Amraoui A; Bhagat Y; Pop M; Cochereau I
    J Fr Ophtalmol; 2010 Apr; 33(4):241-8. PubMed ID: 20223555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children.
    Cochereau I; Meddeb-Ouertani A; Khairallah M; Amraoui A; Zaghloul K; Pop M; Delval L; Pouliquen P; Tandon R; Garg P; Goldschmidt P; Bourcier T
    Br J Ophthalmol; 2007 Apr; 91(4):465-9. PubMed ID: 17050578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.
    Protzko E; Bowman L; Abelson M; Shapiro A;
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3425-9. PubMed ID: 17652708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis.
    Denis F; Chaumeil C; Goldschmidt P; Delval L; Pouliquen P; Cochereau I; Chainier D; De Barbeyrac B
    Eur J Ophthalmol; 2008; 18(6):858-68. PubMed ID: 18988154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis.
    Bremond-Gignac D; Nezzar H; Bianchi PE; Messaoud R; Lazreg S; Voinea L; Speeg-Schatz C; Hartani D; Kaercher T; Kocyla-Karczmarewicz B; Murta J; Delval L; Renault D; Chiambaretta F;
    Br J Ophthalmol; 2014 Jun; 98(6):739-45. PubMed ID: 24526744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.
    Gallenga PE; Lobefalo L; Colangelo L; Della Loggia G; Orzalesi N; Velati P; Bujtar E; Ponte F; Damiani S; Bucci MG; Bonini S; Curatola MR; Palma LA; Bonomi L; Tomazzoli Gerosa L; Pagliarusco A; Milan E; Jauch A
    Ophthalmologica; 1999; 213(4):250-7. PubMed ID: 10420109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients.
    Bremond-Gignac D; Mariani-Kurkdjian P; Beresniak A; El Fekih L; Bhagat Y; Pouliquen P; Delval L; Goldschmidt P; Bingen E; Cochereau I
    Pediatr Infect Dis J; 2010 Mar; 29(3):222-6. PubMed ID: 19935122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis.
    Kernt K; Martinez MA; Bertin D; Stroman D; Cupp G; Martínez C; Tirado M; Guasch J;
    Eur J Ophthalmol; 2005; 15(5):541-9. PubMed ID: 16167284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute neonatal bacterial conjunctivitis: a comparison of fucidic acid to chloramphenicol eye drops.
    Normann EK; Bakken O; Peltola J; Andréasson B; Buhl S; Sigg P; Nielsen K
    Acta Ophthalmol Scand; 2002 Apr; 80(2):183-7. PubMed ID: 11952486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute conjunctivitis. A comparison of fusidic acid viscous eye drops and chloramphenicol.
    Hørven I
    Acta Ophthalmol (Copenh); 1993 Apr; 71(2):165-8. PubMed ID: 8333258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin ophthalmic solution in the treatment of conjunctivitis and blepharitis: a comparison with fusidic acid.
    Adenis JP; Colin J; Verin P; Riss I; Saint-Blancat P
    Eur J Ophthalmol; 1996; 6(4):368-74. PubMed ID: 8997576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis.
    Malminiemi K; Kari O; Latvala ML; Voutilainen R; Miettinen A; Jauch A
    Acta Ophthalmol Scand; 1996 Jun; 74(3):280-4. PubMed ID: 8828727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
    Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL
    Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusidic acid in acute conjunctivitis. Single-blind, randomized comparison of fusidic acid and chloramphenicol viscous eye drops.
    Hvidberg J
    Acta Ophthalmol (Copenh); 1987 Feb; 65(1):43-7. PubMed ID: 3554881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis.
    Jauch A; Fsadni M; Gamba G
    Graefes Arch Clin Exp Ophthalmol; 1999 Sep; 237(9):705-13. PubMed ID: 10447643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of acute infectious conjunctivitis with fusidic acid: a randomised controlled trial.
    Rietveld RP; ter Riet G; Bindels PJ; Bink D; Sloos JH; van Weert HC
    Br J Gen Pract; 2005 Dec; 55(521):924-30. PubMed ID: 16378561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A multicenter randomized study of fusidic acid ophthalmic gel and rifamycine eyedrops in acute conjunctivitis].
    Adenis JP; Arrata M; Gastaud P; Limon S; Massin M
    J Fr Ophtalmol; 1989; 12(4):317-22. PubMed ID: 2697725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
    Torkildsen GL; Cockrum P; Meier E; Hammonds WM; Silverstein B; Silverstein S
    Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.
    Comstock TL; Paterno MR; Usner DW; Pichichero ME
    Paediatr Drugs; 2010 Apr; 12(2):105-12. PubMed ID: 20218747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.